Participants 159 177 3
bipolar 1 disorder
Participants 210 335 5
patients with manic and mixed mood episodes, olanzapine has proven effective in maintaining response, as compared to placebo.
Participants 486 602 6
patients presenting with a mixed index episode who were enrolled in a larger double-blind, placebo-controlled trial.
Participants 603 725 5
Patients who met remission criteria at 2 consecutive weekly visits during 6 to 12 weeks of open-label olanzapine treatment
Participants 968 1068 4
121 of 304 patients (39.8%) met criteria for symptomatic remission in the open-label treatment phase
